A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer – lesions that can become cervical cancer.
The US Centers for Disease Control and Prevention (CDC) reports that just over half (51.1%) of teenagers were fully vaccinated for human papillomavirus (HPV) as of 2018, up 2.5 percentage points from 48.6% in 2017.
The US Centers for Disease Control and Prevention (CDC) reports that almost half (49%) of teenagers have been fully vaccinated for human papillomavirus (HPV), an increase of 5 percentage points from 2016.
Researchers from the National Cancer Institute (NCI) and colleagues have found that the HPV vaccine protects women from a form of the virus that causes oral infection as well as cervical infection.